Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Landsberg

Showing results (761-770 of 1,259) with videos related to

Pageof 126
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomasPhilipp Jansen, Wolfgang Galetzka, Georg C Lodde, et al.
Science Advances|October 29, 2021
Complete protection by a single-dose skin patch-delivered SARS-CoV-2 spike vaccineChristopher L D McMillan, Jovin J Y Choo, Adi Idris, et al.
Experimental Dermatology|April 2, 2015
Genome-wide association study identifies new susceptibility loci for cutaneous lupus erythematosusManfred Kunz, Inke R König, Arne Schillert, et al.
Diseases of Aquatic Organisms|August 1, 2006
Neurological disease in wild loggerhead sea turtles Caretta carettaElliott R Jacobson, Bruce L Homer, Brian A Stacy, et al.
Molecular Cell|March 25, 2022
Structural basis of SARM1 activation, substrate recognition, and inhibition by small moleculesYun Shi, Philip S Kerry, Jeffrey D Nanson, et al.
Nature Medicine|November 4, 2008
5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanomaHendrik Poeck, Robert Besch, Cornelius Maihoefer, et al.
BMC Cancer|May 11, 2021
No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in GermanyRoman Rüdiger, Franziska Geiser, Manuel Ritter, et al.
Neuron|March 3, 2021
SARM1 is a metabolic sensor activated by an increased NMN/NAD<sup>+</sup> ratio to trigger axon degenerationMatthew D Figley, Weixi Gu, Jeffrey D Nanson, et al.
European Journal of Heart Failure|February 4, 2012
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Sean-Xavier Neath, Judd Landsberg, et al.
BMC Cancer|November 1, 2019
A matched-pair analysis on survival and response rates between German and non-German cancer patients treated at a Comprehensive Cancer CenterMarie K Budde, Walther Kuhn, Mignon-Denise Keyver-Paik, et al.
Pageof 126

Showing results (761-770 of 1,259) with videos related to

Sort By:
Pageof 126
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomasPhilipp Jansen, Wolfgang Galetzka, Georg C Lodde, et al.
Science Advances|October 29, 2021
Complete protection by a single-dose skin patch-delivered SARS-CoV-2 spike vaccineChristopher L D McMillan, Jovin J Y Choo, Adi Idris, et al.
Experimental Dermatology|April 2, 2015
Genome-wide association study identifies new susceptibility loci for cutaneous lupus erythematosusManfred Kunz, Inke R König, Arne Schillert, et al.
Diseases of Aquatic Organisms|August 1, 2006
Neurological disease in wild loggerhead sea turtles Caretta carettaElliott R Jacobson, Bruce L Homer, Brian A Stacy, et al.
Molecular Cell|March 25, 2022
Structural basis of SARM1 activation, substrate recognition, and inhibition by small moleculesYun Shi, Philip S Kerry, Jeffrey D Nanson, et al.
Nature Medicine|November 4, 2008
5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanomaHendrik Poeck, Robert Besch, Cornelius Maihoefer, et al.
BMC Cancer|May 11, 2021
No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in GermanyRoman Rüdiger, Franziska Geiser, Manuel Ritter, et al.
Neuron|March 3, 2021
SARM1 is a metabolic sensor activated by an increased NMN/NAD<sup>+</sup> ratio to trigger axon degenerationMatthew D Figley, Weixi Gu, Jeffrey D Nanson, et al.
European Journal of Heart Failure|February 4, 2012
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Sean-Xavier Neath, Judd Landsberg, et al.
BMC Cancer|November 1, 2019
A matched-pair analysis on survival and response rates between German and non-German cancer patients treated at a Comprehensive Cancer CenterMarie K Budde, Walther Kuhn, Mignon-Denise Keyver-Paik, et al.
Pageof 126